Sonographically-guided alcohol injections for Morton's neuroma highly successful

Sonographically-guided alcohol injections has a high success rate and is well tolerated by patients with Morton's neuroma, a common cause of foot pain, according to a recent study conducted by researchers at the Royal National Orthopaedic Hospital and Kingston Hospital NHS Trust in Middlesex, United Kingdom.

Morton's neuroma is a growth of nerve tissue that occurs in a nerve in your foot, often between your third and fourth toes and usually causes a sharp, burning pain in the ball of your foot. For this study, researchers assessed the efficacy of a series of alcohol injections into the lesion.

"I felt many patients with Morton's neuroma were undergoing an operation that was unnecessary and that the neuroma could be successfully treated in a less invasive manner," said David Connell, MD, lead author of the study.

The study consisted of 101 patients with Morton's neuroma. An average of 4.1 treatments per person were administered, and follow-up images were obtained at a mean of 21.1 months after the last treatment.

According to the study, there was a technical success rate of 100%. In 94% of the patients, partial or total symptom improvement was reported, with 84% becoming totally pain free. Thirty patients underwent sonography at six months after the last injection and showed a 30% decrease in the size of the neuroma.

'surprisingly, most patients maintain innervation to the toes despite the alcohol ablation," said Dr. Connell. "This means that they don't have the permanent numbness and loss of sensation that accompanies resection of the nerve at surgery," he said.

http://www.arrs.org

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Ozempic and similar drugs may lower risks for opioid and alcohol use disorders